Cytokines in rheumatoid arthritis. Potential targets for pharmacological intervention.

作者: Zoltan Szekanecz , Alisa E. Koch , Steven L. Kunkel , Robert M. Strieter

DOI: 10.2165/00002512-199812050-00004

关键词:

摘要: The ingress of inflammatory leucocytes into the synovium is a crucial step in pathogenesis rheumatoid arthritis (RA). Cytokines are mediators involved events, adhesive mechanisms, angiogenesis and osteopenia associated with RA. Pro- anti-inflammatory cytokines, growth factors chemokines all have an important role these processes. Because efficacy currently used antirheumatic therapy often limited, there need for more specific intervention strategies. Anticytokine may include use monoclonal antibodies, antagonistic soluble cytokine receptors, receptor antagonists, somatic gene transfer or other approaches. Hopefully, study cytokines their interactions will lead to development new immunomodulatory strategies that benefit patients

参考文章(152)
S Jaglal, E C Keystone, A Shore, Enhanced interleukin 1 generation by monocytes in vitro is temporally linked to an early event in the onset or exacerbation of rheumatoid arthritis. Clinical and Experimental Immunology. ,vol. 65, pp. 293- 302 ,(1986)
Roubenoff R, Holland Sm, Hellmann Db, Ward Lm, Roubenoff Ra, Rheumatoid cachexia: depletion of lean body mass in rheumatoid arthritis. Possible association with tumor necrosis factor. The Journal of Rheumatology. ,vol. 19, pp. 1505- 1510 ,(1992)
J. Keffer, L. Probert, H. Cazlaris, S. Georgopoulos, E. Kaslaris, D. Kioussis, G. Kollias, Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. The EMBO Journal. ,vol. 10, pp. 4025- 4031 ,(1991) , 10.1002/J.1460-2075.1991.TB04978.X
E Racadot, D Wendling, J Wijdenes, Treatment of severe rheumatoid arthritis by anti-interleukin 6 monoclonal antibody. The Journal of Rheumatology. ,vol. 20, pp. 259- 262 ,(1993)
S. M. Goodman, A. M. E. Nouri, G. S. Panayi, Cytokines and the chronic inflammation of rheumatic disease. II. The presence of interleukin-2 in synovial fluids. Clinical and Experimental Immunology. ,vol. 58, pp. 402- 409 ,(1984)
P. Calabresi, J. G. Beitz, A. Raymond, M. Yamamoto, J. W. Clark, J. Kato, A. R. Frackelton, N. Sato, Platelet-derived growth factor indirectly stimulates angiogenesis in vitro. American Journal of Pathology. ,vol. 142, pp. 1119- 1130 ,(1993)
GS Firestein, JM Alvaro-Gracia, R Maki, JM Alvaro-Garcia, Quantitative analysis of cytokine gene expression in rheumatoid arthritis. Journal of Immunology. ,vol. 144, pp. 3347- 3353 ,(1990)
S M Wahl, L M Wahl, A E Berger, G L Costa, M Corcoran, Transforming growth factor-beta mediates IL-1-dependent induction of IL-1 receptor antagonist. Journal of Immunology. ,vol. 150, pp. 3553- 3560 ,(1993)
Yuti Chernajovsky, Alex Annenkov, Charlotte Herman, Kostas Triantaphyllopoulos, David Gould, Hanna Dreja, Sasha P. Moyes, J Ludovic Croxford, Rizgar A. Mageed, Osvaldo L. Podhajcer, David Baker, Gene therapy for rheumatoid arthritis. Theoretical considerations. Drugs & Aging. ,vol. 12, pp. 29- 41 ,(1998) , 10.2165/00002512-199812010-00004